Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Min Yin
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
Jiangsu Province Hospital,
Nanjing Medical University
ORCID:
0009-0009-5638-4908
Observed ORCID:
0009-0009-5638-4908
OpenAlex ID:
A5068067914
Hemithyroidectomy Versus Total Thyroidectomy for Sporadic Medullary Thyroid Cancer: A Chinese Nationwide Large-Scale Cohort Study
2025
·
Xiao Shi
, Cenkai Shen
, et al.
·
Journal of the National Comprehensive Cancer Network
·
28
Updated Thresholds of Basal Calcitonin Level and Extent of Lymph Node Metastasis in Initially Treated Medullary Thyroid Cancer
2025
·
Yuxin Du
, Cenkai Shen
, et al.
·
JAMA Otolaryngology–Head & Neck Surgery
·
19
Targeting CDK2 Confers Vulnerability to Lenvatinib Via Driving Senescence in Anaplastic Thyroid Cancer
2024
·
Ben Ma
, Youzhou Sang
, et al.
·
Advanced Science
·
13
PDF
Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2023
·
Cenkai Shen
, Xiao Shi
, et al.
·
Clinical Cancer Research
·
11
Revised Perspective on the AJCC Staging System for Medullary Thyroid Cancer: A Study of Two Nationwide Cohorts
2025
·
Cenkai Shen
, Yuxin Du
, et al.
·
Journal of the National Comprehensive Cancer Network
·
10
Association of Lymph Nodes Positive Rate With the Risk of Recurrence in Patients With Stage T1 Papillary Thyroid Cancer
2024
·
Chao Qin
, Sijia Cai
, et al.
·
Journal of the Endocrine Society
·
6
Decoding Lymph Node Skip Metastasis: Impact on Long-Term Outcomes in Stage T1 Papillary Thyroid Carcinoma
2025
·
Sijia Cai
, Chao Qin
, et al.
·
European Journal of Endocrinology
·
4
Long-term efficacy of lobectomy for stage T1 papillary thyroid carcinoma with varying degrees of lymph node metastasis
2024
·
Chao Qin
, Sijia Cai
, et al.
·
Frontiers in Endocrinology
·
4
[Development and validation of nomogram for predicting prognosis of patients with laryngeal squamous cell carcinoma after surgery].
2022
·
Juan Xu
, Liqing Zhang
, et al.
·
PubMed Central
·
2
PDF
LINC02516 promotes tumor growth and migration in papillary thyroid cancer by modulating YAP1 phosphorylation
2026
·
Weibo Xu
, Min Yin
, et al.
·
Current Genomics
Supplementary Methods 1 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Data from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Table S2 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Figure S1 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
PDF
Figure S1 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Figure S2 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Table S2 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Figure S2 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
PDF
Figure S3 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
PDF
Figure S3 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Table S1 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Table S1 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Data from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Show more works
View as search
Works count:
23
Citation count:
96
H-index:
6
I10-index:
5
Year
Topic
Type